Ropenefix Overdosage

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Full Prescribing Info

Overdosage

Intentional overdosing of Meropenem FOR INJECTION USP is unlikely, although overdosing could occur during therapy, particularly in patients with renal impairment. Limited post-marketing experience indicates that if adverse events occur following overdosage, they are consistent with the adverse event profile described in ADVERSE REACTIONS, and are generally mild in severity and resolve on withdrawal or dose reduction. Symptomatic treatments should be considered. In normal individuals, rapid renal elimination will occur. Hemodialysis will remove Meropenem FOR INJECTION USP and its metabolite.

meropenem

Manufacturer:

Zeiss

Distributor:

D & G Pharma

Marketer:

D & G Pharma